BrainStorm Cell Therapeutics
BCLI
#10412
Rank
โ‚ฌ5.15 M
Marketcap
0,47ย โ‚ฌ
Share price
-6.78%
Change (1 day)
-68.29%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ7.71 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ7.71 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BrainStorm Cell Therapeutics - Total liabilities on balance sheet (from 2002 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ9.22 M12.44%
2023-12-31โ‚ฌ8.2 M-23.28%
2022-12-31โ‚ฌ10.68 M21.85%
2021-12-31โ‚ฌ8.77 M-31.69%
2020-12-31โ‚ฌ12.84 M-23.31%
2019-12-31โ‚ฌ16.74 M208.35%
2018-12-31โ‚ฌ5.43 M17.54%
2017-12-31โ‚ฌ4.61 M462.42%
2016-12-31โ‚ฌ0.82 M-69.58%
2015-12-31โ‚ฌ2.69 M1.47%
2014-12-31โ‚ฌ2.66 M84.93%
2013-12-31โ‚ฌ1.43 M64.64%
2012-12-31โ‚ฌ0.87 M-9.64%
2011-12-31โ‚ฌ0.96 M-16.9%
2010-12-31โ‚ฌ1.16 M-33.3%
2009-12-31โ‚ฌ1.74 M-17.34%
2008-12-31โ‚ฌ2.11 M-12.22%
2007-12-31โ‚ฌ2.4 M24.97%
2006-12-31โ‚ฌ1.92 M
2006-03-31โ‚ฌ7.31 M5301.11%
2005-03-31โ‚ฌ0.13 M251.56%
2004-03-31โ‚ฌ0.03 M66.09%
2003-03-31โ‚ฌ0.02 M76.29%
2002-03-31โ‚ฌ0.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
โ‚ฌ31.52 B 408,552.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚ฌ1.66 B 21,476.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚ฌ0.92 B 11,845.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ9.35 B 121,138.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ0.43 B 5,573.53%๐Ÿ‡บ๐Ÿ‡ธ USA